# HS research update (2026-07-01): What’s new on PubMed?

Canonical URL: https://acneinversa.life/en/blog/hs-research-update-2026-07-01/
Markdown URL: https://acneinversa.life/en/blog/hs-research-update-2026-07-01.md
Plain text URL: https://acneinversa.life/en/blog/hs-research-update-2026-07-01.txt
Language: en
Category: Research
Published: 2026-07-01
Last updated: 2026-07-01
Author: Dr. rer. nat. Dennis Alexander Kwiatkowski (Biochemist, Scientific Writer and Pharma Expert)
Tags: Acne Inversa, Hidradenitis Suppurativa, HS, Research, hidradenitis suppurativa, acne inversa, research update, biologics, comorbidities, jak inhibitor, pain, quality of life, surgery, wound care

> A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.

Medical disclaimer: This website is for general educational information only and does not replace medical advice, diagnosis, or treatment. Please speak with qualified medical professionals about symptoms or treatment decisions.

## Article

## Publication overview

This update includes **33 PubMed publications with abstracts** from the monitoring window **2026-06-17 to 2026-07-01**. The most common themes are **biologics, quality of life, pain, comorbidities, surgery**.

- Compared with the previous update: not automatically assessed.
- No guideline/NEJM/Lancet-style high-impact matches with abstracts in this window.
- This is a research overview, not a guideline update or medical recommendation.

## Top highlights

The most useful signal this round is not a single treatment instruction. It is what researchers are looking at more closely: wound healing after procedures, possible new anti-inflammatory approaches, care quality, and comorbidities.

- **Modalities of Combined Medical and Surgical Treatment in Hidradenitis Suppurativa: A Systematic Review of Efficacy and Safety.:** The abstract describes a systematic review. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, and sinus tracts that lead to significant morbidity and impaired quality of life. Although both biolo… What makes it notable here is that it approaches HS through **surgery, quality of life, biologics, pain, wound care**. The main limitation to keep in mind is: Its strength depends on the quality and comparability of the included studies, and an abstract does not expose every methodological weakness. ([PMID 42334818](https://pubmed.ncbi.nlm.nih.gov/42334818/))
- **Upadacitinib for Severe Refractory Hidradenitis Suppurativa After Failure of Multiple Systemic Therapies: A Case Report.:** The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis characterized by recurrent nodules, abscesses, draining sinus tracts, and substantial impairment in quality of life. Management of severe, refractory… What makes it notable here is that it approaches HS through **pain, biologics, jak inhibitor, quality of life**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42344817](https://pubmed.ncbi.nlm.nih.gov/42344817/))
- **Surgical Interventions for the Treatment of Hidradenitis Suppurativa: A Systematic Review of Surgical Impact on DLQI.:** The abstract describes a systematic review. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful cutaneous nodules, abscesses, and fistulas in regions containing apocrine glands. OBEJECTIVE: This study reviews the literature… What makes it notable here is that it approaches HS through **pain, quality of life, surgery, wound care**. The main limitation to keep in mind is: Its strength depends on the quality and comparability of the included studies, and an abstract does not expose every methodological weakness. ([PMID 42337805](https://pubmed.ncbi.nlm.nih.gov/42337805/))
- **Patient-reported outcomes of laser hair removal for hidradenitis suppurativa: an exploratory cross-sectional survey.:** The abstract describes a survey-based report. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease often requiring multimodal therapy. Laser hair removal (LHR) is an emerging treatment option, yet patient-centered data is limited. What makes it notable here is that it approaches HS through **biologics, pain, quality of life**. The main limitation to keep in mind is: Surveys can show practice patterns and opinions, but they do not by themselves show which approach works best for patients. ([PMID 42342886](https://pubmed.ncbi.nlm.nih.gov/42342886/))
- **Surgical Management of Inframammary Hidradenitis Suppurativa with Reduction Mammaplasty Technique: A Report of Two Cases.:** The abstract describes a new publication. In practical terms, it focuses on this question or finding: Background and Clinical Significance: Hidradenitis suppurativa (HS) is a chronic, debilitating skin disorder that often affects the inframammary fold (IMF). While surgical management, particularly wide local excision… What makes it notable here is that it approaches HS through **biologics, surgery, wound care**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42347090](https://pubmed.ncbi.nlm.nih.gov/42347090/))

## Featured publication

The featured paper is **Upadacitinib for Severe Refractory Hidradenitis Suppurativa After Failure of Multiple Systemic Therapies: A Case Report.** in **Cureus** ([PMID 42344817](https://pubmed.ncbi.nlm.nih.gov/42344817/)). The abstract mainly says this: Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis characterized by recurrent nodules, abscesses, draining sinus tracts, and substantial impairment in quality of life. Management of severe, refractory…

Why it stands out: it connects to the priority themes **pain, biologics, jak inhibitor, quality of life** and shows what HS researchers are trying to clarify right now. For readers, it matters because it gives one concrete example of how the field is framing a practical question or possible mechanism. The main limitation is that From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full.

## What this may mean for patients (carefully, no advice)

If you live with HS, research updates can help you make sense of what’s being studied — for example which outcomes (pain, quality of life) researchers measure, or which comorbidities are increasingly part of the conversation.

But even when a study sounds promising, it usually does not tell you what is right **for you personally**. Consider using new findings as questions for your next appointment (e.g., “What are realistic goals for me?” or “Which related conditions should we keep an eye on?”), not as instructions.

## What we don’t know / limitations

- This update includes **only** PubMed items with an abstract (without an abstract, safe summarization is limited).
- Studies vary widely (design, populations, outcome measures).
- This update provides **no** treatment advice and cannot assess individual risk.

## Important: decisions belong in clinician conversations

This article is an editorial overview and is **not medically reviewed**. If something here worries or interests you, use it as a conversation starter for your next appointment. Decisions should always be made with qualified healthcare professionals.

## FAQ

### Why are there only a few new publications here?
This format is deliberately strict: it includes only new PubMed items from the monitoring window that have an abstract and were not already covered in earlier posts.

### Does a new paper mean my treatment should change?
No. A single publication can be useful to know about, but it is usually not enough to guide decisions for one specific person.

### Why emphasize limitations so much?
Because abstracts show only part of the picture. Study design, patient population, endpoints, and follow-up all matter before results can be interpreted responsibly.

## Sources & original papers

Each point below maps to an original source (PubMed link, plus DOI/PMCID when available).

## References

1. Mature tertiary lymphoid structures in pilonidal sinus disease. - JID innovations : skin science from molecules to population health, 2026 — PMID 42327670 · DOI 10.1016/j.xjidi.2026.100479 · PMCID PMC13279301 - https://pubmed.ncbi.nlm.nih.gov/42327670/
2. Hidradenitis Suppurativa: Diagnosis and Treatment Challenges in Primary Care. - Pediatric clinics of North America, 2026 — PMID 42349979 · DOI 10.1016/j.pcl.2026.03.004 - https://pubmed.ncbi.nlm.nih.gov/42349979/
3. Icariin Regulates Acne Pathophysiology and Extracellular Matrix Protein Synthesis: Implications for Acne Vulgaris and Atrophic Acne Scar Management. - Experimental dermatology, 2026 — PMID 42366890 · DOI 10.1111/exd.70310 - https://pubmed.ncbi.nlm.nih.gov/42366890/
4. Activation of MyD88/IRAK1 axis and downstream proinflammatory signaling in healthy adult and neonatal African American skin. - JID innovations : skin science from molecules to population health, 2026 — PMID 42338433 · DOI 10.1016/j.xjidi.2026.100488 · PMCID PMC13285840 - https://pubmed.ncbi.nlm.nih.gov/42338433/
5. Surgical Interventions for the Treatment of Hidradenitis Suppurativa: A Systematic Review of Surgical Impact on DLQI. - Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2026 — PMID 42337805 · DOI 10.1097/DSS.0000000000004992 - https://pubmed.ncbi.nlm.nih.gov/42337805/
6. The Impact of Chronic Spontaneous Urticaria on Sleep-A Systematic Review. - Dermatology and therapy, 2026 — PMID 42366326 · DOI 10.1007/s13555-026-01837-4 - https://pubmed.ncbi.nlm.nih.gov/42366326/
7. Emerging synthetic drugs for the management of hidradenitis suppurativa: a comprehensive update. - Expert opinion on pharmacotherapy, 2026 — PMID 42342652 · DOI 10.1080/14656566.2026.2695100 - https://pubmed.ncbi.nlm.nih.gov/42342652/
8. Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages. - Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 — PMID 42363729 · DOI 10.1111/jdv.70546 - https://pubmed.ncbi.nlm.nih.gov/42363729/
9. Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices. - Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 — PMID 42363716 · DOI 10.1111/jdv.70576 - https://pubmed.ncbi.nlm.nih.gov/42363716/
10. Bone health in women with hidradenitis suppurativa: addressing osteoporosis risks and management options. - International journal of women's dermatology, 2026 — PMID 42369852 · DOI 10.1097/JW9.0000000000000262 · PMCID PMC13308930 - https://pubmed.ncbi.nlm.nih.gov/42369852/
11. Long-term follow-up and response to elosulfase alfa in mucopolysaccharidosis type IVA: a single-center cohort from the Czech Republic. - Orphanet journal of rare diseases, 2026 — PMID 42363262 · DOI 10.1186/s13023-026-04439-7 - https://pubmed.ncbi.nlm.nih.gov/42363262/
12. Patient-reported outcomes of laser hair removal for hidradenitis suppurativa: an exploratory cross-sectional survey. - Lasers in medical science, 2026 — PMID 42342886 · DOI 10.1007/s10103-026-04893-6 · PMCID PMC13294157 - https://pubmed.ncbi.nlm.nih.gov/42342886/
13. The Effects of Immune Checkpoint Inhibitors on Hidradenitis Suppurativa: A Scoping Review. - Skin appendage disorders, 2026 — PMID 42344962 · DOI 10.1159/000551945 · PMCID PMC13290252 - https://pubmed.ncbi.nlm.nih.gov/42344962/
14. Psoriasis, Atopic Dermatitis, Acne, Inverse Psoriasis and Hidradenitis: A Case Report of Multiple Disease in a Same Young Patient. - Clinical case reports, 2026 — PMID 42343938 · DOI 10.1002/ccr3.72354 · PMCID PMC13288607 - https://pubmed.ncbi.nlm.nih.gov/42343938/
15. Structural basis for selective and potent degradation of IRAK4 by KT-474. - Nature communications, 2026 — PMID 42336816 · DOI 10.1038/s41467-026-74105-w - https://pubmed.ncbi.nlm.nih.gov/42336816/
16. Context-dependent short-chain fatty acids in inflammatory skin diseases: Immunometabolic mechanisms, evidence boundaries, and translational perspectives. - Pharmacological research, 2026 — PMID 42336338 · DOI 10.1016/j.phrs.2026.108318 - https://pubmed.ncbi.nlm.nih.gov/42336338/
17. Modalities of Combined Medical and Surgical Treatment in Hidradenitis Suppurativa: A Systematic Review of Efficacy and Safety. - Dermatology and therapy, 2026 — PMID 42334818 · DOI 10.1007/s13555-026-01836-5 - https://pubmed.ncbi.nlm.nih.gov/42334818/
18. Single-cell spatial profiling identifies a mucosal-like epithelial signature in Hidradenitis suppurativa tunnels. - JCI insight, 2026 — PMID 42325093 · DOI 10.1172/jci.insight.200187 - https://pubmed.ncbi.nlm.nih.gov/42325093/
19. Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study. - Pediatric rheumatology online journal, 2026 — PMID 42321814 · DOI 10.1186/s12969-026-01236-1 - https://pubmed.ncbi.nlm.nih.gov/42321814/
20. Posterior Arm Artery Perforator Flap: An Ultrafast and Reproducible Perforator Flap Dissection Technique. - Plastic and reconstructive surgery. Global open, 2026 — PMID 42325477 · DOI 10.1097/GOX.0000000000007840 · PMCID PMC13278249 - https://pubmed.ncbi.nlm.nih.gov/42325477/
21. A case of hidradenitis suppurativa complicated by necrotizing soft tissue infection. - The American journal of emergency medicine, 2026 — PMID 42320420 · DOI 10.1016/j.ajem.2026.06.022 - https://pubmed.ncbi.nlm.nih.gov/42320420/
22. The follicular microbiome in hair-follicle-associated inflammatory diseases: A systematic review. - Clinical and experimental dermatology, 2026 — PMID 42315132 · DOI 10.1093/ced/llag251 - https://pubmed.ncbi.nlm.nih.gov/42315132/
23. Beyond Drainage: Clinical-Ultrasound Correlation Supports a Broader Definition of the Active Tunnel in Hidradenitis Suppurativa. - Dermatology and therapy, 2026 — PMID 42313355 · DOI 10.1007/s13555-026-01828-5 - https://pubmed.ncbi.nlm.nih.gov/42313355/
24. Decoding Inflammation in Hidradenitis Suppurativa: Serum Cytokines as Biomarkers of Disease Severity and Treatment Outcome-Systematic Review. - Journal of clinical medicine, 2026 — PMID 42355867 · DOI 10.3390/jcm15124699 · PMCID PMC13302279 - https://pubmed.ncbi.nlm.nih.gov/42355867/
25. Hidradenitis suppurativa and psoriasis: shared immunological links with metabolic-associated steatotic liver disease. - Frontiers in immunology, 2026 — PMID 42327723 · DOI 10.3389/fimmu.2026.1831174 · PMCID PMC13280206 - https://pubmed.ncbi.nlm.nih.gov/42327723/
26. Differentiation defects reposition sebaceous glands as inflammatory instigators in the early pathogenesis of hidradenitis suppurativa. - Frontiers in immunology, 2026 — PMID 42338586 · DOI 10.3389/fimmu.2026.1785747 · PMCID PMC13283874 - https://pubmed.ncbi.nlm.nih.gov/42338586/
27. Surgical Management of Inframammary Hidradenitis Suppurativa with Reduction Mammaplasty Technique: A Report of Two Cases. - Reports (MDPI), 2026 — PMID 42347090 · DOI 10.3390/reports9020177 · PMCID PMC13306240 - https://pubmed.ncbi.nlm.nih.gov/42347090/
28. Scrotal elephantiasis secondary to hidradenitis suppurativa: a rare case report. - Frontiers in medicine, 2026 — PMID 42318388 · DOI 10.3389/fmed.2026.1867933 · PMCID PMC13272065 - https://pubmed.ncbi.nlm.nih.gov/42318388/
29. Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa. - International journal of women's dermatology, 2026 — PMID 42369842 · DOI 10.1097/JW9.0000000000000261 · PMCID PMC13308921 - https://pubmed.ncbi.nlm.nih.gov/42369842/
30. Upadacitinib for Severe Refractory Hidradenitis Suppurativa After Failure of Multiple Systemic Therapies: A Case Report. - Cureus, 2026 — PMID 42344817 · DOI 10.7759/cureus.109546 · PMCID PMC13289800 - https://pubmed.ncbi.nlm.nih.gov/42344817/
31. Tofacitinib in Overlapping Autoimmune and Autoinflammatory Disorders: A Case Report of a Dual Graham-Little-Piccardi-Lasseur Syndrome and Hidradenitis Suppurativa. - Case reports in dermatology, 2026 — PMID 42375516 · DOI 10.1159/000552170 · PMCID PMC13313624 - https://pubmed.ncbi.nlm.nih.gov/42375516/
32. Psychiatric Outcomes after GLP-1 Receptor Agonists versus Metformin in Hidradenitis Suppurativa. - Skin appendage disorders, 2026 — PMID 42344960 · DOI 10.1159/000551916 · PMCID PMC13290251 - https://pubmed.ncbi.nlm.nih.gov/42344960/
33. Hidradenitis Suppurativa Presenting with Ocular Manifestations in a 44-Year-Old Male: A Case Report. - Case reports in ophthalmology, 2026 — PMID 42311869 · DOI 10.1159/000551644 · PMCID PMC13271692 - https://pubmed.ncbi.nlm.nih.gov/42311869/